Advanced International Journal for Research
E-ISSN: 3048-7641
•
Impact Factor: 9.11
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with AIJFR
Upcoming Conference(s) ↓
WSMCDD-2025
GSMCDD-2025
Conferences Published ↓
RBS:RH-COVID-19 (2023)
ICMRS'23
PIPRDA-2023
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 7 Issue 2
March-April 2026
Indexing Partners
Vitamin D as an Immunomodulator in Infectious Diseases: A Biochemical Review
| Author(s) | Mr. Akash R, Mrs. Supriya M S, Mr. Shams Tabriz, Dr. Bhagya HM, Dr. Mohammed Yaseen |
|---|---|
| Country | India |
| Abstract | Vitamin D, traditionally associated with calcium homeostasis and skeletal health, has emerged as a critical immunomodulatory hormone influencing host defense against infectious diseases. Increasing evidence highlights its role in regulating innate and adaptive immune responses through genomic and non-genomic mechanisms mediated by the vitamin D receptor (VDR). This review provides a comprehensive synthesis of the biochemical pathways, molecular mechanisms, and clinical implications of vitamin D in infectious diseases. Vitamin D enhances innate immunity by inducing antimicrobial peptides such as cathelicidin and defensins, improving epithelial barrier integrity, and promoting autophagy and phagocytosis. In adaptive immunity, it suppresses pro-inflammatory T helper (Th1 and Th17) responses while promoting regulatory T cells, thereby maintaining immune homeostasis. Epidemiological studies consistently associate vitamin D deficiency with increased susceptibility to respiratory, bacterial, and viral infections, including COVID-19. However, randomized controlled trials yield inconsistent findings due to heterogeneity in baseline vitamin D status, dosing strategies, and population characteristics. This review critically evaluates current clinical evidence, highlighting its preventive potential, limitations in therapeutic application, and areas requiring further investigation. Despite strong mechanistic support, standardized clinical guidelines remain lacking. Future research should focus on personalized supplementation strategies, large-scale randomized trials, and exploration of gene–nutrient interactions. Vitamin D represents a promising adjunct in infectious disease prevention and immune modulation, but its optimal clinical application requires further high-quality evidence. |
| Keywords | Vitamin D; Immunomodulation; Infectious diseases; Innate immunity; Adaptive immunity; Cytokines; Supplementation |
| Field | Medical / Pharmacy |
| Published In | Volume 7, Issue 2, March-April 2026 |
| Published On | 2026-03-24 |
Share this

E-ISSN 3048-7641
CrossRef DOI is assigned to each research paper published in our journal.
AIJFR DOI prefix is
10.63363/aijfr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.